OmniComm's TrialMaster Added to Kendle's Suite of eClinical Solutions in Multi-Year Agreement
Fort Lauderdale, FL-September 30, 2009
In a multi-year enterprise-wide agreement Kendle will add OmniComm’s TrialMaster EDC solution to its current eClinical offerings.
“Efficient delivery of high-quality data is critical to Kendle’s continued success as a leading provider of clinical data management services,” said John Fontenault, Executive Director and Global Head, Clinical Data Management and Technology. "The addition of the TrialMaster EDC solution to our existing offerings supports Kendle’s focus on providing our global biopharmaceutical customers with cost-effective access to the best eClinical solutions to accelerate their Phase I through IV clinical trials. The TrialMaster platform offers the right mix of functionality to streamline the study development process and drive efficient study operations.”
"We are excited to be working with Kendle to meet the needs of its diverse customer base," said Stephen Johnson, COO of OmniComm Systems. "Kendle is one of the largest and most respected and successful top-tier global CROs with extensive eClinical experience, having conducted more than 250 trials utilizing EDC technologies to expedite the clinical trials process. We look forward to providing them the eClinical solutions and services needed to support their continued delivery of best-in-class clinical development services to their customers.”
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
